{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:20:21Z","timestamp":1789122021475,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.carrev.2019.11.011","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T21:32:57Z","timestamp":1574199177000},"page":"230-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation"],"prefix":"10.1016","volume":"21","author":[{"given":"Nauman","family":"Khalid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Aftab","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. James","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Shlofmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anees","family":"Musallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson L.","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2019.11.011_bb0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1751-2824.2012.01560.x","article-title":"ECMO \u2013 the clinician\u2019s view","volume":"7","author":"Fraser","year":"2012","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.carrev.2019.11.011_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0885066610384061","article-title":"A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients","volume":"26","author":"Allen","year":"2011","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.carrev.2019.11.011_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jtcvs.2016.02.067","article-title":"Contemporary extracorporeal membrane oxygenation therapy in adults: fundamental principles and systematic review of the evidence","volume":"152","author":"Squiers","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2019.11.011_bb0020","first-page":"E166","article-title":"Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology","volume":"7","author":"Makdisi","year":"2015","journal-title":"J Thorac Dis"},{"issue":"5 Suppl 1","key":"10.1016\/j.carrev.2019.11.011_bb0025","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/PCC.0b013e318292dd10","article-title":"Extracorporeal membrane oxygenation circuitry","volume":"14","author":"Lequier","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.carrev.2019.11.011_bb0030","unstructured":"Extracorporeal Life Support Organization. Available from: http:\/\/www.elso.org. [Accessed June 1, 2019]."},{"key":"10.1016\/j.carrev.2019.11.011_bb0035","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(09)61069-2","article-title":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial","volume":"374","author":"Peek","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.carrev.2019.11.011_bb0040","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.11.011_bb0045","unstructured":"ECMO Learning Package. Available from: https:\/\/www.aci.health.nsw.gov.au\/__data\/assets\/pdf_file\/0007\/306583\/ECMO_Learning_package.pdf. Last accessed June 1, 2019."},{"key":"10.1016\/j.carrev.2019.11.011_bb0050","unstructured":"MAUDE: Manufacturer and User Facility Device Experience. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfmaude\/search.cfm. Last accessed June 1, 2019."},{"key":"10.1016\/j.carrev.2019.11.011_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4244\/EIJ-D-18-01021","article-title":"Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database","volume":"15","author":"Khalid","year":"2019","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2019.11.011_bb0060","first-page":"157","article-title":"Adverse events and modes of failure related to the FilterWire EZ embolic protection system: lessons learned from an analytic review of the FDA MAUDE database","volume":"94","author":"Khalid","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.11.011_bb0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.carrev.2019.03.010","article-title":"Adverse events and modes of failure related to Impella RP: insights from the manufacturer and user facility device experience (MAUDE) database","volume":"20","author":"Khalid","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.11.011_bb0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.carrev.2019.03.009","article-title":"Techniques to optimize the use of optical coherence tomography: insights from the manufacturer and user facility device experience (MAUDE) database","volume":"20","author":"Shlofmitz","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.11.011_bb0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.carrev.2019.02.016","article-title":"Adverse events associated with the use of guide extension catheters during percutaneous coronary intervention: reports from the manufacturer and user facility device experience (MAUDE) database","volume":"20","author":"Chen","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.11.011_bb0080","doi-asserted-by":"crossref","unstructured":"Khalid N, Rogers T, Shlofmitz E, Chen Y, Waksman R. Response to the letter by Bilazarian et al. regarding the article, \u201cAdverse events and modes of failure related to Impella RP: Insights from the Manufacturer and User Facility Device Experience (MAUDE) database\u201d. Cardiovasc Revasc Med. 2019 May 13. pii: S1553\u20138389(19)30309\u20134. https:\/\/doi.org\/10.1016\/j.carrev.2019.05.010.","DOI":"10.1016\/j.carrev.2019.05.010"},{"key":"10.1016\/j.carrev.2019.11.011_bb0085","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4244\/EIJ-D-19-00279R","article-title":"Reply to Chhabra et al, \u201cImpella device use in high-risk PCI\u201d","volume":"15","author":"Khalid","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.11.011_bb0090","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.athoracsur.2013.09.008","article-title":"Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients","volume":"97","author":"Cheng","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2019.11.011_bb0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3988\/jcn.2015.11.4.383","article-title":"Neurologic complications of extracorporeal membrane oxygenation","volume":"11","author":"Nasr","year":"2015","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.carrev.2019.11.011_bb0100","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jacc.2018.11.038","article-title":"Venoarterial ECMO for adults: JACC scientific expert panel","volume":"73","author":"Guglin","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.11.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112316","article-title":"Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange--retrospective analysis of 265 cases","volume":"9","author":"Lubnow","year":"2014","journal-title":"PLoS One"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919307572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919307572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:17:06Z","timestamp":1761560226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919307572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1553838919307572"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.11.011","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}